About Jagpreet

Jagpreet Chhatwal, PhD is a senior scientist at the Institute for Technology Assessment at Massachusetts General Hospital, and an assistant professor at Harvard Medical School. His research focuses on the application of mathematical modeling to inform health policies. He leads health outcomes and cost-effectiveness projects in multiple disease areas including hepatitis C, hepatocellular carcinoma, and liver transplantation. Dr. Chhatwal’s recent research on hepatitis C has informed several highly-debated questions surrounding the cost-effectiveness of hepatitis C screening and treatments in the United States, India and elsewhere. His work has been featured in leading media such as The Wall Street Journal, Forbes, and National Public Radio. He currently serves as a cost-effectiveness and decision analysis editor of Clinical Gastroenterology and Hepatology.

This speaker will be presenting at the following session(s)

  • How to develop an investment case?

    Parallel workshop

    Day: 1 November

    Time: 15:30

    Presentations:

    • An investment case: The why and the proposed WHO approach.
      Dr. Yvan Hutin, World Health Organization
    • Indian case study: Need for an investment case.
    • Dr. Rakesh Aggarwal, Sanjay Gandhi Postgraduate Institute of Medical Sciences and Dr. Jagpreet Chhatwal, Harvard Medical School and Massachusetts General Hospital
    • Breakout interactive session.
    • Debrief of the solution to the exercise.
    • WHO wrap-up: How economic analysis was used in the case of Egypt.

    Session objectives:

    • Describe the role of an investment case/economic analysis in the national planning process.
    • Differentiate a cost effectiveness analysis from health care perspective from a broader cost-benefit analysis/investment case.
    • Identify the elements needed for a national investment case/economic analysis in practice.